The program combines advanced diagnostics, multidisciplinary clinical expertise, and personalized plans to improve cognitive, physical, and overall functional performance in a medical, evidence-based setting.

Aviv emphasizes its hyperbaric program is medical and evidence-based, not wellness-focused, integrating diagnostics and personalized treatment to drive outcomes.

UHMS accreditation is recognized by The Joint Commission as the exclusive hyperbaric-specific certification through its complementary accrediting organization initiative, with months of staff preparation behind Aviv’s attainment.

Dr. Amir Hadanny, Chief Medical Officer and CEO, says the accreditation validates Aviv’s scientific and clinical foundation and reinforces hyperbaric medicine as a rigorously studied discipline.

Aviv Clinics is a leading research and treatment hub for cognitive and functional decline, and it partners with the Sagol Center at Shamir Medical Center in Israel to advance evidence-based aging-related care.

The broader program and partnership with the Sagol Center underscore Aviv’s aging-related cognitive and physical decline treatments as evidence-based.

Readers can find more information at aviv-clinics.com and uhms.org.

Aviv Clinics has earned UHMS accreditation, signaling a clinical-grade hyperbaric program with consistent care and accountability for patients and referring physicians.

This UHMS accreditation makes Aviv the first U.S. center focused on emerging indications in hyperbaric medicine, setting it apart from facilities that offer general oxygen therapy.

Aviv’s program targets indications such as PTSD, Long COVID, traumatic brain injury, stroke, healthy aging, and athletic performance.

The release positions Aviv as a global reference point in hyperbaric medicine and highlights its commitment to expanding access to scientifically validated HBOT programs.

UHMS is the world’s leading authority on hyperbaric medicine, and its accreditation is the gold standard for safety and operational excellence in the field.